Business Context and Reporting Period
This Form 8-K Current Report was filed by cbdMD, Inc. on September 15, 2020. The filing discloses significant changes in executive leadership, specifically the appointment of a new Chief Financial Officer (CFO) and the resignation of the previous CFO and Chief Operating Officer (COO), both effective October 1, 2020.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on executive compensation and employment terms.
Material Changes
Appointment of T. Ronan Kennedy as CFO
- Effective Date: October 1, 2020.
- Base Salary: $250,000 annually.
- Equity Grant: 50,000 shares of restricted stock and options to purchase 350,000 shares of common stock.
- Option Vesting: Options vest in equal amounts over three years (Oct 1, 2021, 2022, 2023) at exercise prices of $3.50 (100,000 shares), $5.00 (125,000 shares), and $6.50 (125,000 shares).
- Severance: If terminated without cause, the company must pay the remaining base salary for the term, with a minimum of six months' salary. In the event of a Change of Control, severance is the greater of 1.5x base salary or remaining base salary.
Resignation of Mark Elliott
- Effective Date: October 1, 2020.
- Transition Period: October 1, 2020, through February 28, 2021.
- Compensation: Salary and benefits paid through December 31, 2021.
- Equity Treatment: All previously issued options and restricted stock fully vest. The company will extend the exercise period and allow cashless exercise.
- New Grant: Options to purchase 300,000 shares at $2.60 per share, exercisable for 3 years on a cashless basis.
- Release: Mr. Elliott releases the company from claims; the company releases Mr. Elliott from non-competition obligations.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future business performance. The primary risk disclosed relates to the transition of financial leadership and the associated compensation obligations.
Investor Verification Checklist
- Verify the total cost of the separation package for Mark Elliott, including the value of the 300,000 new options and the salary extension through 2021.
- Review the full text of the Executive Employment Agreement (Exhibit 10.1) and Separation Agreement (Exhibit 10.2) for specific performance metrics tied to Mr. Kennedy's bonus.
- Assess the impact of the new CFO's option strike prices ($3.50, $5.00, $6.50) relative to the current market price of YCBD stock.
- Confirm the timeline for the transition of duties between Mr. Elliott and Mr. Kennedy to ensure continuity in financial reporting.